Complete Genomics, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 55   

Articles published

GNOM 3.14
price chart
Medical Technology Adds .6 Billion Annually to Economy
Complete Genomics Inc. in Mountain View, California researches the largest clinical application of future genomic-sequencing technology.
Related articles »  
The Promise And Problem Of Genomic Marketing
A genome is an organism's complete set of DNA, a compound that contains the genetic instructions needed to develop and direct the activities of every organism.
Quantifying separation and similarity in a Saccharomyces cerevisiae ...
Genomic DNA was extracted from colonies with 15 μl of 1.25 mg ml−1 Zymolyase solution dissolved in 1.2 M sorbitol and 0.1 M KH2PO4 at pH 7.2 and treated with EMA to bind unwanted DNA fragments (Rueckert and Morgan, 2007).
Illumina's (ILMN) CEO Jay Flatley on Q2 2014 Results - Earnings Call ...
Good day, ladies and gentlemen, and welcome to the Q2 2014 Illumina Inc. Earnings Conference Call. My name is Whitley, and I'll be ... We are very pleased to recently disclose alongside Genomics England that Illumina Cambridge will be the preferred ...
Related articles »  
California Powerhouse: O'Melveny
In a landmark cross-border transaction, a multioffice, multipractice O'Melveny team in 2012 represented Chinese genome sequencing company BGI-Shenzhen in its $117.6 million acquisition of Mountain View, California- based Complete Genomics Inc. and ...
100K Genomes Project is moving forward with medicine centers to open in 2015
Under the project, 100,000 complete human genomes will be sequenced, with the data being applied to improve the treatment of rare diseases and common cancers.
TRADE NEWS: Agilent Technologies Introduces New Exome Optimized for ...
Agilent Technologies Inc. (NYSE:A) today introduced the SureSelect Clinical Research Exome. The performance-optimized exome design was developed in collaboration with researchers from Emory University and the Children's Hospital of Philadelphia.
Related articles »  
Safeguard Scientifics Announces Second Quarter 2014 Financial Results
Operating Highlights - AdvantEdge continues to gain scale through strategic and organic growth acquisitions, completing eight M&A transactions since 2009.
Related articles »  
Big Brothers Big Sisters of Massachusetts Bay Welcomes Two New Board ...
From 2001-2008, Dr. Kucherlapati served as the first Scientific Director of the Harvard Medical School-Partners Healthcare Center for Genetics and Genomics. His research focuses on gene mapping ... His recent CEO level assignments include the Federal ...
Genome Sequencing Technologies � The Next Big Thing In Healthcare
Indeed, a significant amount of resources is currently being devoted to the field of genomics, all in an attempt to achieve breakthroughs in the analysis of different medical conditions, like the mutation of genes.